Deitelzweig, Steve
21  results:
Search for persons X
?
1

Effectiveness and Safety of Apixaban Versus Warfarin in Obe..:

Deitelzweig, Steve ; Sah, Janvi ; Kang, Amiee...
The American Journal of Cardiology.  163 (2022)  - p. 43-49 , 2022
 
?
2

Thrombotic and bleeding events, mortality, and anticoagulan..:

Deitelzweig, Steve ; Luo, Xuemei ; Nguyen, Jennifer L....
Journal of Thrombosis and Thrombolysis.  53 (2022)  4 - p. 766-776 , 2022
 
?
3

Correction: Thrombotic and bleeding events, mortality, and ..:

Deitelzweig, Steve ; Luo, Xuemei ; Nguyen, Jennifer L....
Journal of Thrombosis and Thrombolysis.  54 (2022)  4 - p. 696-696 , 2022
 
?
6

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Re..:

Deitelzweig, Steve ; Luo, Xuemei ; Gupta, Kiran...
Clinical and Applied Thrombosis/Hemostasis.  24 (2018)  4 - p. 602-611 , 2018
 
?
9

Estimation of the impact of warfarin's time-in-therapeutic ..:

Amin, Alpesh ; Deitelzweig, Steve ; Jing, Yonghua...
Journal of Thrombosis and Thrombolysis.  38 (2014)  2 - p. 150-159 , 2014
 
?
10

Comparison of Medical Costs of Patients With Atrial Fibrill..:

Amin, Alpesh ; Deitelzweig, Steve ; Jing, Yonghua...
Clinical and Applied Thrombosis/Hemostasis.  21 (2013)  3 - p. 235-240 , 2013
 
?
13

Effectiveness and Safety of Oral Anticoagulants among NVAF ..:

Deitelzweig, Steve ; Keshishian, Allison ; Kang, Amiee...
https://vbn.aau.dk/da/publications/96ea3d05-d9d8-4c58-b7f4-58614fb74e5f.  , 2020
 
?
 
?
15

Apixaban 5 and 2.5 mg twice-daily versus warfarin for strok..:

Li, Xiaoyan ; Keshishian, Allison ; Hamilton, Melissa...
https://vbn.aau.dk/da/publications/96bed900-ee6b-4ee5-a26b-ced2c5bb9fbd.  , 2018
 
1-15